Case number 1:23-cv-00153
Vanda Pharmaceuticals Inc. v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 20, 2025 | 175 | NOTICE OF SERVICE of (1) Defendants' Objections and Responses to Plaintiff's Amended First Set of Requests for Admission to Apotex (Nos. 1-25); (2) Defendants' Objections and Responses to Plaintiff's Amended First Set of Requests to Apotex for the Production of Documents and Things (Nos. 1-16); (3) Defendants' Objections and Responses to Plaintiff's Amended First Set of Interrogatories to Apotex (Nos. 1-11); (4) Defendants' Objections and Responses to Plaintiff's Amended Second Set of Requests to Apotex for the Production of Documents and Things (Nos. 17-26); and (5) Defendants' Objections and Responses to Plaintiff's Amended Second Set of Interrogatories to Apotex (Nos. 12-13) filed by Apotex Corp., Apotex Inc..(Ekiner, Kaan) (Entered: 06/20/2025) (2) |
| May 21, 2025 | 174 | NOTICE OF SERVICE of (1) Defendants' Objections and Responses to Plaintiff's First Set of Requests for Admission to Apotex (Nos. 1-25); (2) Defendants' Objections and Responses to Plaintiff's Second Set of Requests to Apotex for the Production of Documents and Things (Nos. 17-26); and (3) Defendants' Objections and Responses to Plaintiff's Second Set of Interrogatories to Apotex (Nos. 12-13) filed by Apotex Corp., Apotex Inc..(Ekiner, Kaan) (Entered: 05/21/2025) (2) |
| May 20, 2025 | 173 | NOTICE OF SERVICE of (1) Plaintiff's Amended First Set of Requests for Admission to Defendants (Nos. 1-25), (2) Plaintiff's Amended First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-16), (3) Plaintiff's Amended First Set of Interrogatories to Defendants (Nos. 1-11), (4) Plaintiff's Amended Second Set of Requests to Defendants for the Production of Documents and Things (Nos. 17-26), and (5) Plaintiff's Amended Second Set of Interrogatories to Defendants (Nos. 12-13) filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 05/20/2025) (4) |
| May 16, 2025 | 172 | NOTICE OF SERVICE of Plaintiff's Supplemental Initial Infringement Charts filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 05/16/2025) (3) |
| May 13, 2025 | 171 | SO ORDERED, re (185 in 1:23-cv-00152-JLH, 169 in 1:23-cv-00153-JLH) Stipulation to Extend Time for (1) Plaintiff's to Produce Initial Infringement Contentions to May 16, 2025 and (2) Defendants to Produce Initial Invalidity Contentions and Invalidity References to July 7, 2025. Signed by Judge Jennifer L. Hall on 5/13/2025. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 05/13/2025) (3) |
| May 12, 2025 | 170 | NOTICE OF SERVICE of (1) Defendants' Supplemental Rule 26(a)(1) Initial Disclosures; and (2) Defendants' Supplemental Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Apotex Corp., Apotex Inc..(Ekiner, Kaan) (Entered: 05/12/2025) (2) |
| May 12, 2025 | 169 | STIPULATION TO EXTEND TIME (1) Plaintiff's to Produce Initial Infringement Contentions and (2) Defendants to Produce Initial Invalidity Contentions and Invalidity References to See Stip for Details - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 05/12/2025) (3) |
| May 12, 2025 | 168 | NOTICE OF SERVICE of (1) Plaintiff's Supplemental Rule 26(a)(1) Initial Disclosures, (2) Plaintiff's Supplemental Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery, and (3) Plaintiff's Supplemental Initial Disclosure of Accused Products, Asserted Patents, and Damages Models filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 05/12/2025) (3) |
| May 8, 2025 | 167 | Pro Hac Vice Fee - Credit Card Payment received for Connor S. Romm. ( re 166 MOTION for Pro Hac Vice Appearance of Attorney Connor S. Romm )( Payment of $ 50, receipt number ADEDC-4682169).(Silver, Daniel) (Entered: 05/08/2025) (0) |
| May 8, 2025 | 166 | MOTION for Pro Hac Vice Appearance of Attorney Connor S. Romm - filed by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Certification for Connor S. Romm)(Silver, Daniel) (Entered: 05/08/2025) (0) |
| May 6, 2025 | 165 | SO ORDERED, re (19 in 1:24-cv-01344-JLH, 164 in 1:23-cv-00153-JLH) Stipulation fand Order to Consolidate Actions. C.A. No. 24-1344-JLH will be consolidated into C.A. No. 23-153-JLH for all purposes and all papers will be filed in C.A. No. 23-153-JLH. (*Reset Scheduling Order Deadlines: Fact Discovery completed by 9/19/2025; Expert Discovery due by 1/9/2026; Interim Status Report due by 7/22/2025; Dispositive and Daubert Motions due by 1/23/2026; Answering Brief due 2/13/2026; Reply Brief due 2/27/2026; A Motion Hearing is set for 3/20/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall; Joint Status Report regarding First Trial due by 4/15/2026; Proposed Pretrial Order due by 7/20/2026; A Pretrial Conference is set for 7/27/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall; A 4-day Jury Trial is set for 8/3/2026 at 09:00 AM in Courtroom 6D before Judge Jennifer L. Hall; See Order for complete details). Signed by Judge Jennifer L. Hall on 5/6/2025. Associated Cases: 1:23-cv-00153-JLH, 1:24-cv-01344-JLH(ceg) Modified on 5/6/2025 (ceg). (Entered: 05/06/2025) (4) |
| Apr 30, 2025 | 164 | STIPULATION and [Proposed] Order to Consolidate Actions by Vanda Pharmaceuticals Inc.. (Joyce, Alexandra) (Entered: 04/30/2025) (4) |
| Apr 23, 2025 | 163 | NOTICE requesting Clerk to remove April Weisbruch as co-counsel.. (Silver, Daniel) (Entered: 04/23/2025) (2) |
| Apr 7, 2025 | 162 | NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests for Admission to Defendants (Nos. 1-25), (2) Plaintiff's Second Set of Interrogatories to Defendants (Nos. 12-13), and (3) Plaintiff's Second Set of Requests to Defendants for the Production of Documents and Things (Nos. 17-26) filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 04/07/2025) (3) |
| Apr 4, 2025 | 161 | NOTICE of Deposition of Defendant Apotex Under Federal Rule of Civil Procedure 30(b)(6) by Vanda Pharmaceuticals Inc. (Silver, Daniel) (Entered: 04/04/2025) (17) |
| Apr 4, 2025 | 160 | NOTICE to Take Deposition of Alexander Rocher on April 30, 2025 filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 04/04/2025) (2) |
| Apr 4, 2025 | 159 | NOTICE to Take Deposition of Bhupesh Singh on April 28, 2025 filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 04/04/2025) (2) |
| Apr 2, 2025 | 158 | Official Transcript of Markman Hearing held on 03/06/25 before Judge Jennifer L. Hall. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/23/2025. Redacted Transcript Deadline set for 5/5/2025. Release of Transcript Restriction set for 7/1/2025. (Triozzi, Heather) (Entered: 04/02/2025) (56) |
| Mar 13, 2025 | 157 | ORAL ORDER: Pursuant to the parties' express request for the Court to construe "altenolol" in the patents-in-suit as "atenolol" (No. 23-152, D.I. 160, 169; No. 23-153, D.I. 147, 156), IT IS SO ORDERED. Ordered by Judge Jennifer L. Hall on 3/13/2025. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(twk) Modified on 3/14/2025 (ceg). (Entered: 03/13/2025) (0) |
| Mar 13, 2025 | 156 | Joint STATUS REPORT by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 03/13/2025) (2) |
| Mar 5, 2025 | 155 | ORDER granting (167 in 1:23-cv-00152-JLH, 154 in 1:23-cv-00153-JLH) Plaintiff's Motion for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices for purposes of the March 6, 2025 Markman Hearing. Signed by Judge Jennifer L. Hall on 3/5/2025. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 03/05/2025) (2) |
| Mar 4, 2025 | 154 | MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order)(Silver, Daniel) (Entered: 03/04/2025) (0) |
| Mar 4, 2025 | 153 | Pro Hac Vice Fee - Credit Card Payment received for Mary Schnoor. ( re 152 MOTION for Pro Hac Vice Appearance of Attorney Mary Schnoor )( Payment of $ 50, receipt number ADEDC-4627500).(Silver, Daniel) (Entered: 03/04/2025) (0) |
| Mar 4, 2025 | 152 | MOTION for Pro Hac Vice Appearance of Attorney Mary Schnoor - filed by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Certification for Mary Schnoor)(Silver, Daniel) (Entered: 03/04/2025) (0) |
| Feb 26, 2025 | 151 | Pro Hac Vice Fee - Credit Card Payment received for Samoneh Kadivar Schickel. ( re 150 MOTION for Pro Hac Vice Appearance of Attorney Samoneh Kadivar Schickel )( Payment of $ 50, receipt number ADEDC-4623585).(Silver, Daniel) (Entered: 02/26/2025) (0) |
| Feb 26, 2025 | 150 | MOTION for Pro Hac Vice Appearance of Attorney Samoneh Kadivar Schickel - filed by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Certification for Samoneh Kadivar Schickel)(Silver, Daniel) (Entered: 02/26/2025) (0) |
| Feb 20, 2025 | 149 | NOTICE OF SERVICE of (1) Apotex's Objections and Responses to Plaintiff's First Set of Requests to Apotex for the Production of Documents and Things (Nos. 1-16); and (2) Apotex's Objections and Responses to Plaintiff's First Set of Interrogatories to Apotex (Nos. 1-11) filed by Apotex Corp., Apotex Inc..(Ekiner, Kaan) (Entered: 02/20/2025) (2) |
| Feb 20, 2025 | 148 | NOTICE OF SERVICE of (1) Vanda's Objections and Responses to Defendants' Joint First Set of Interrogatories (Nos. 1-13) and (2) Vanda's Objections and Responses to Defendants' Joint First Set of Requests for Production of Documents (Nos. 1-53) filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 02/20/2025) (3) |
| Jan 21, 2025 | 147 | Letter to The Honorable Jennifer L. Hall from Daniel M. Silver, Esq. regarding Joint Claim Construction Chart. (Attachments: # 1 Amended Joint Claim Construction Chart)(Silver, Daniel) (Entered: 01/21/2025) (0) |
| Jan 14, 2025 | 146 | NOTICE OF SERVICE of (1) Defendants' First Set of Interrogatories to Vanda Pharmaceuticals Inc. (Nos. 1-13); and (2) Defendants' First Set of Requests for Production of Documents and Things (Nos. 1-53) to Plaintiff Vanda Pharmaceuticals Inc. filed by Apotex Inc., Apotex Corp..(Ekiner, Kaan) (Entered: 01/14/2025) (2) |
| Jan 14, 2025 | 145 | NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-16) and (2) Plaintiff's First Set of Interrogatories to Defendants (Nos. 1-11) filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 01/14/2025) (3) |
| Jan 13, 2025 | 144 | SO ORDERED, re (143 in 1:23-cv-00153-JLH, 156 in 1:23-cv-00152-JLH) Stipulation and Order to Extend the Deadline for the parties to meet and confer to file Amended Joint Claim Construction Chart to January 21, 2025. Signed by Judge Jennifer L. Hall on 1/13/2025. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 01/13/2025) (3) |
| Jan 13, 2025 | 143 | STIPULATION TO EXTEND TIME the Deadline for the Parties to Meet and Confer to File Amended Joint Claim Construction Chart to January 21, 2025 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 01/13/2025) (3) |
| Jan 10, 2025 | 142 | ORAL ORDER: Having reviewed the parties' letter (C.A. 23-152, D.I. 154, C.A. 23-153, D.I. 141), IT IS HEREBY ORDERED that, at the March 6, 2025 Markman Hearing, the parties shall have two hours split evenly between the two sides. Ordered by Judge Jennifer L. Hall on 1/10/2025. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 01/10/2025) (0) |
| Jan 6, 2025 | 141 | Joint Letter to The Honorable Jennifer L. Hall from Nathan R. Hoeschen regarding Claim Construction Hearing. (Hoeschen, Nathan) (Entered: 01/06/2025) (1) |
| Jan 6, 2025 | 140 | Joint APPENDIX re (152 in 1:23-cv-00152-JLH) Joint Claim Construction Brief, (139 in 1:23-cv-00153-JLH) Joint Claim Construction Brief by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1-12)(Silver, Daniel) (Entered: 01/06/2025) (0) |
| Jan 6, 2025 | 139 | JOINT CLAIM CONSTRUCTION BRIEF filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 01/06/2025) (30) |
| Jan 3, 2025 | 138 | STIPULATION TO EXTEND TIME the Deadline for the Filing of Technology Tutorials to January 10, 2025 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 01/03/2025) (3) |
| Dec 24, 2024 | 137 | NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Apotex Inc., Apotex Corp..(Ekiner, Kaan) (Entered: 12/24/2024) (2) |
| Dec 10, 2024 | 136 | NOTICE OF SERVICE of Plaintiff's Claim Construction Reply Brief filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 12/10/2024) (3) |
| Dec 4, 2024 | 135 | STIPULATION TO EXTEND TIME the deadline to amend the pleadings and for the joinder of parties to December 10, 2024 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 12/04/2024) (2) |
| Dec 2, 2024 | 134 | NOTICE OF SERVICE of Defendants' Responsive Claim Construction Brief filed by Apotex Inc., Apotex Corp..(Ekiner, Kaan) (Entered: 12/02/2024) (2) |
| Nov 27, 2024 | 133 | STIPULATION TO EXTEND TIME to amend the pleadings and for the joinder of parties to December 4, 2024 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 11/27/2024) (2) |
| Nov 22, 2024 | 132 | SO ORDERED, re (138 in 1:23-cv-00152-JLH, 131 in 1:23-cv-00153-JLH) STIPULATION TO EXTEND TIME the deadline to amend the pleadings and for the joinder of parties to December 2, 2024. Signed by Judge Jennifer L. Hall on 11/22/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(twk) (Entered: 11/22/2024) (2) |
| Nov 21, 2024 | 131 | STIPULATION TO EXTEND TIME the deadline to amend the pleadings and for the joinder of parties to December 2, 2024 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 11/21/2024) (2) |
| Nov 7, 2024 | 130 | STIPULATED PROTECTIVE ORDER. Signed by Judge Jennifer L. Hall on 11/7/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 11/07/2024) (30) |
| Nov 6, 2024 | 129 | NOTICE OF SERVICE of Plaintiff's Opening Claim Construction Brief and Exhibits filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 11/06/2024) (3) |
| Nov 6, 2024 | 128 | PROPOSED Stipulated Protective Order, by Vanda Pharmaceuticals Inc. (Silver, Daniel) Modified on 11/6/2024 (ceg). (Entered: 11/06/2024) (30) |
| Oct 30, 2024 | 127 | STIPULATION TO EXTEND TIME the deadline for the parties to submit a proposed protective order to November 6, 2024 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 10/30/2024) (2) |
| Oct 27, 2024 | 126 | Official Transcript of Status Conference held on 09-06-24 before Judge Hall. Court Reporter Stacy Ingram,Email: stacy_ingram@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/18/2024. Redacted Transcript Deadline set for 11/27/2024. Release of Transcript Restriction set for 1/27/2025. (Ingram, Stacy) (Entered: 10/27/2024) (11) |
| Oct 24, 2024 | 125 | STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit Proposed Protective Order to October 30, 2024 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 10/24/2024) (2) |
| Oct 21, 2024 | 124 | JOINT Claim Construction Chart, by Vanda Pharmaceuticals Inc. (Silver, Daniel) Modified on 10/22/2024 (ceg). (Entered: 10/21/2024) (9) |
| Oct 16, 2024 | 123 | STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Proposed Protective Order to October 24, 2024 - filed by Vanda Pharmaceuticals Inc.. (Joyce, Alexandra) (Entered: 10/16/2024) (2) |
| Oct 14, 2024 | 122 | NOTICE OF SERVICE of Vanda Pharmaceutical Inc.'s Identification of Claim Terms for Construction filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 10/14/2024) (3) |
| Oct 8, 2024 | 121 | NOTICE OF SERVICE of (1) Vanda Pharmaceutical Inc.'s Rule 26(a)(1) Initial Disclosures and (2) Vanda Pharmaceuticals Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 10/08/2024) (3) |
| Oct 8, 2024 | 120 | NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Apotex Corp., Apotex Inc..(Ekiner, Kaan) (Entered: 10/08/2024) (2) |
| Oct 7, 2024 | 119 | NOTICE OF SERVICE of (1) Defendants Apotex Inc. and Apotex Corp.'s Rule 26(a)(1) Initial Disclosures; and (2) Defendants Apotex Inc. and Apotex Corp.'s Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Apotex Corp., Apotex Inc..(Ekiner, Kaan) (Entered: 10/07/2024) (2) |
| Oct 3, 2024 | 118 | STIPULATION TO EXTEND TIME the deadline for the parties to submit a proposed protective order to October 17, 2024 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 10/03/2024) (2) |
| Sep 30, 2024 | 117 | STIPULATION TO EXTEND TIME the deadline for the parties to serve their initial disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Default Standard for Discovery to October 7, 2024 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 09/30/2024) (2) |
| Sep 23, 2024 | 116 | SCHEDULING ORDER: Case Nos. 23-152-JLH and 23-153-JLH are coordinated for pretrial purposes ONLY. Joinder of Parties due by 11/21/2024. Amended Pleadings due by 11/21/2024. Fact Discovery completed by 5/9/2025. Expert Discovery due by 10/3/2025. Joint Claim Construction Chart due by 10/21/2024. Joint Claim Construction Brief due by 1/6/2025. Amended Joint Claim Construction Chart due no earlier than 1/13/2025. A Markman Hearing is set for 3/6/2025 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Joint Status Report due 7 days after Markman decision. Dispositive and Daubert Motions due by 10/24/2025. Answering Briefs due by 11/21/2025. Reply Briefs due by 12/5/2025. A Hearing on any pending Dispositive and Daubert motions is set for 1/16/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Joint Proposed Pretrial Order due by 3/13/2026. A Pretrial Conference is set for 3/20/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. The first 4-day Jury Trial is set for 4/20/2026 at 09:00 AM in Courtroom 6D before Judge Jennifer L. Hall. (*See Order for details). Signed by Judge Jennifer L. Hall on 9/23/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 09/23/2024) (17) |
| Sep 13, 2024 | 115 | PROPOSED Scheduling Order, by Vanda Pharmaceuticals Inc. (Silver, Daniel) Modified on 9/13/2024 (ceg). (Entered: 09/13/2024) (17) |
| Sep 6, 2024 | 114 | NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 09/06/2024) (3) |
| Aug 28, 2024 | 113 | NOTICE OF SERVICE of Plaintiff Vanda Pharmaceuticals Inc.'s Initial Disclosure of Accused Products, Asserted Patent, and Damages Models filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 08/28/2024) (3) |
| Aug 12, 2024 | 112 | ORAL ORDER Resetting Rule 16(b) Conference: At the request of counsel, IT IS HEREBY ORDERED that the Scheduling Conference scheduled for August 27, 2024, is RESCHEDULED for September 6, 2024, at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Ordered by Judge Jennifer L. Hall on 8/12/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 08/12/2024) (0) |
| Aug 6, 2024 | 111 | ORAL ORDER Setting Rule 16(b) Conference: A Scheduling Conference is scheduled for August 27, 2024 at 2:00 PM in Courtroom 6D before Judge Jennifer L. Hall. Ordered by Judge Jennifer L. Hall on 8/6/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 08/06/2024) (0) |
| Aug 1, 2024 | 110 | Letter to The Honorable Jennifer L. Hall from Daniel M. Silver regarding Scheduling Order and Disputed Issues. (Attachments: # 1 Proposed Scheduling Order)(Silver, Daniel) (Entered: 08/01/2024) (0) |
| Jul 29, 2024 | 109 | Pro Hac Vice Fee - Credit Card Payment received for Jason A. Leonard. ( re 108 MOTION for Pro Hac Vice Appearance of Attorney Jason A. Leonard )( Payment of $ 50, receipt number ADEDC-4462989).(Silver, Daniel) (Entered: 07/29/2024) (0) |
| Jul 29, 2024 | 108 | MOTION for Pro Hac Vice Appearance of Attorney Jason A. Leonard - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 07/29/2024) (3) |
| Jul 25, 2024 | 107 | SO ORDERED, re (114 in 1:23-cv-00152-JLH, 106 in 1:23-cv-00153-JLH) Stipulation and Order to Extend Time to file a proposed Scheduling Order to August 1, 2024. Signed by Judge Jennifer L. Hall on 7/25/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 07/25/2024) (2) |
| Jul 25, 2024 | 106 | STIPULATION TO EXTEND TIME the Deadline to File a Proposed Scheduling Order to August 1, 2024 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 07/25/2024) (2) |
| Jul 16, 2024 | 105 | SO ORDERED, re (104 in 1:23-cv-00153-JLH, 112 in 1:23-cv-00152-JLH) Stipulation and Order to Extend Time to file a proposed Scheduling Order to July 25, 2024. Signed by Judge Jennifer L. Hall on 7/16/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 07/16/2024) (2) |
| Jul 15, 2024 | 104 | STIPULATION TO EXTEND TIME to file a proposed Scheduling Order (see D.I. 111 in C.A. No. 23-152; D.I. 103 in C.A. No. 23-153) to July 25, 2024 - filed by Teva Pharmaceuticals U.S.A., Inc.. (Hoeschen, Nathan) (Entered: 07/15/2024) (2) |
| Jun 27, 2024 | 103 | ORDER: IT IS HEREBY ORDERED that Defendants' Motion for Judgment on the Pleadings (C.A. No. 23-152, D.I. 98; C.A. No. 23-153, D.I. 90) is DENIED. Within 21 days, the parties shall jointly prepare and file a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent". (*See Order for details). Signed by Judge Jennifer L. Hall on 6/27/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 06/27/2024) (3) |
| Feb 2, 2024 | 102 | ORAL ORDER: These cases having been reassigned to me on January 12, 2024, and it appearing that there are pending Motions (No. 23-152, D.I. 74; No. 23-153, D.I. 67) that relate to pleadings that are no longer the operative pleadings, and it further appearing that the parties agreed on May 8, 2023, that the pending motions should be withdrawn (No. 23-152, D.I. 93; No. 23-153, D.I. 85), IT IS HEREBY ORDERED that the Motions are DISMISSED. Ordered by Judge Jennifer L. Hall on 2/2/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 02/02/2024) (0) |
| Aug 23, 2023 | 101 | REQUEST for Oral Argument by Teva Pharmaceuticals U.S.A., Inc., Apotex Corp. re (98 in 1:23-cv-00152-CFC) MOTION for Judgment on the Pleadings . (Hoeschen, Nathan) (Entered: 08/23/2023) (2) |
| Aug 16, 2023 | 100 | REPLY BRIEF re 90 MOTION for Judgment on the Pleadings filed by Apotex Corp., Apotex Inc.. (Ekiner, Kaan) (Entered: 08/16/2023) (18) |
| Aug 7, 2023 | 99 | NOTICE of Change of Address of Sterne, Kessler, Goldstein & Fox P.L.L.C. by Teva Pharmaceuticals U.S.A., Inc. (DiBenedetto, Emily) (Entered: 08/07/2023) (2) |
| Aug 1, 2023 | 98 | SO ORDERED, re (97 in 1:23-cv-00153-CFC, 105 in 1:23-cv-00152-CFC) Joint STIPULATION TO EXTEND TIME for defendants Apotex Inc., Apotex Corp., and Teva Pharmaceuticals USA, Inc. to file a reply brief in support of defendants' Motion for Judgment on the Pleadings to August 16, 2023, filed by Teva Pharmaceuticals U.S.A., Inc. Reset Briefing Schedule: re (98 in 1:23-cv-00152-CFC, 90 in 1:23-cv-00153-CFC) MOTION for Judgment on the Pleadings. Reply Brief due 8/16/2023. Signed by Judge Colm F. Connolly on 8/1/2023. Associated Cases: 1:23-cv-00152-CFC, 1:23-cv-00153-CFC(kmd) (Entered: 08/01/2023) (2) |
| Aug 1, 2023 | 97 | Joint STIPULATION TO EXTEND TIME for defendants Apotex Inc., Apotex Corp., and Teva Pharmaceuticals USA, Inc. to file a reply brief in support of defendants' Motion for Judgment on the Pleadings to August 16, 2023 - filed by Teva Pharmaceuticals U.S.A., Inc.. (DiBenedetto, Emily) (Entered: 08/01/2023) (2) |
| Jul 27, 2023 | 96 | DEFICIENCY NOTICE by the Court issued to Vanda Pharmaceuticals Inc. re (103 in 1:23-cv-00152-CFC, 95 in 1:23-cv-00153-CFC) Answering Brief in Opposition. Pursuant to the Court's Standing Order Regarding Briefing in All Cases, dated November 10, 2022, "[t]he covers of briefs filed in connection with all motions except for motions in limine included in a pretrial order shall be as follows: i. Opening Brief - Blue; ii. Answering Brief - Red; iii. Reply Brief - Gray." Courtesy copies of D.I. 103 in 1:23-cv-00152-CFC, 95 in 1:23-cv-00153-CFC are not in compliance with the Court's standing order. Please resubmit courtesy copies of your brief with the corrected covers. Associated Cases: 1:23-cv-00152-CFC, 1:23-cv-00153-CFC (kmd) (Entered: 07/27/2023) (2) |
| Jul 26, 2023 | 95 | ANSWERING BRIEF in Opposition re 90 MOTION for Judgment on the Pleadings filed by Vanda Pharmaceuticals Inc..Reply Brief due date per Local Rules is 8/2/2023. (Attachments: # 1 Certificate of Compliance)(Joyce, Alexandra) (Entered: 07/26/2023) (0) |
| Jul 10, 2023 | 94 | SO ORDERED, re (101 in 1:23-cv-00152-CFC, 93 in 1:23-cv-00153-CFC) STIPULATION TO EXTEND TIME the Deadline for Plaintiff Vanda Pharmaceuticals Inc. to Respond to Defendants' Motion for Judgment on the Pleadings to July 26, 2023, filed by Vanda Pharmaceuticals Inc. Reset Briefing Schedule: re (98 in 1:23-cv-00152-CFC) (90 in 1:23-cv-00153-CFC) MOTION for Judgment on the Pleadings. Answering Brief due 7/26/2023. Signed by Judge Colm F. Connolly on 7/10/2023. Associated Cases: 1:23-cv-00152-CFC, 1:23-cv-00153-CFC(kmd) (Entered: 07/10/2023) (3) |
| Jul 10, 2023 | 93 | STIPULATION TO EXTEND TIME the Deadline for Plaintiff Vanda Pharmaceuticals Inc. to Respond to Defendants' Motion for Judgment on the Pleadings to July 26, 2023 - filed by Vanda Pharmaceuticals Inc.. (Joyce, Alexandra) (Entered: 07/10/2023) (3) |
| Jun 28, 2023 | 90 | MOTION for Judgment on the Pleadings - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1 Text of Proposed Order)(Ekiner, Kaan) (Entered: 06/28/2023) (Text of Proposed Order) (2) |
| Jun 28, 2023 | 92 | DECLARATION re 90 MOTION for Judgment on the Pleadings by Apotex Corp., Apotex Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Ekiner, Kaan) (Entered: 06/28/2023) (Exhibit 2) (5) |
| Jun 28, 2023 | 92 | DECLARATION re 90 MOTION for Judgment on the Pleadings by Apotex Corp., Apotex Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Ekiner, Kaan) (Entered: 06/28/2023) (Exhibit 1) (3) |
| Jun 28, 2023 | 92 | DECLARATION re 90 MOTION for Judgment on the Pleadings by Apotex Corp., Apotex Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Ekiner, Kaan) (Entered: 06/28/2023) (Main Document) (2) |
| Jun 28, 2023 | 91 | OPENING BRIEF in Support re 90 MOTION for Judgment on the Pleadings filed by Apotex Corp., Apotex Inc..Answering Brief/Response due date per Local Rules is 7/12/2023. (Ekiner, Kaan) (Entered: 06/28/2023) (27) |
| Jun 28, 2023 | 90 | MOTION for Judgment on the Pleadings - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1 Text of Proposed Order)(Ekiner, Kaan) (Entered: 06/28/2023) (Main Document) (2) |
| Jun 9, 2023 | 89 | ANSWER to 88 Answer to Amended Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 06/09/2023) (19) |
| May 26, 2023 | 88 | ANSWER to Amended Complaint, re: 86 Amended Complaint , COUNTERCLAIM against Vanda Pharmaceuticals Inc. by Apotex Corp., Apotex Inc..(Ekiner, Kaan) (Entered: 05/26/2023) (29) |
| May 16, 2023 | 87 | NOTICE of Withdrawal of Motion for Judgment on the Pleadings (C.A. No. 23-152, D.I. 85; C.A. No. 23-153, D.I. 77) by Teva Pharmaceuticals U.S.A., Inc. (Hoeschen, Nathan) (Entered: 05/16/2023) (2) |
| May 12, 2023 | 86 | Amended Complaint* (1) |
